Status | 已發表Published |
PRS65 Effect and cost of traditional Chinese medicine Xiyanping injection for treating community acquired pneumonia among adults in China. Value in Health. 2019; 22: S175. | |
Shi, H.; Guo, W. J. ; Zhu, H.; Li, M.; Ung, O. L. C.; Hu, H.; Han, S. | |
2019-05-01 | |
Source Publication | Value in Health |
Pages | S361-S361 |
Abstract | Objectives: To evaluate the effect and cost of Xiyanping injection (herb-derived compound, andrographolide sulfonate) on the treatment of community acquired pneumonia among adults using real world data in China. Methods: Data about patients diagnosed with community acquired pneumonia identified with ICD-10 diagnosis code dated between 2013 and 2014 was extracted fromthe Hospital Information SystemDatabase of 2 hospitals in Jiangxi Province. Patients were divided into 4 groups according to the age and causative agent: young patients (15-64 years) with viral pneumonia (group 1) or bacterial pneumonia (group 2), and elderly patients (over 65 years) with viral pneumonia (group 3) or bacterial pneumonia (group 4). Cure rate, improvement rate, uncured rate, death rate, average hospitalization days and total hospitalization costs were compared between patients treated with Xiyanping injection and those treated with conventional treatment. Results: 114 patients treated with Xiyanping injection (60, 21, 18 and 15 patients in group 1-4, respectively) and 3,107 patients with conventional treatment (893, 376, 1,322 and 516 patients in group 1-4, respectively) were included. After prosperity score matching, no significant differences in the cure rate, improvement rate, uncured rate, and death rate when comparing patients treated with Xiyanping injection and those treated with conventional treatment. Patients treated with Xiyanping injection had significantly shorter hospital stay for Group 1 patients (5.14262.54 vs. 6.9863.86 days), Group 2 patients (5.0062.61 vs. 7.9263.75 days) and Group 4 patients (5.5862.97 vs. 9.2563.19 days). The total cost of hospitalization was lower for patients treated with Xiyanping injection than those treated with conventional treatment in Group 1, 2 and 4 although there were no significant statistics differences. Conclusions: Comparing with conventional treatment, Xiyanping injection provided the same clinical outcome but with shorter hospital stay resulting in reduced hospitalization cost for adults with community acquired pneumonia in China. |
Keyword | Xiyanping traditional Chinese medicine |
Language | 英語English |
The Source to Article | PB_Publication |
PUB ID | 43959 |
Document Type | Conference paper |
Collection | Institute of Chinese Medical Sciences |
Corresponding Author | Hu, H. |
Recommended Citation GB/T 7714 | Shi, H.,Guo, W. J. ,Zhu, H.,et al. PRS65 Effect and cost of traditional Chinese medicine Xiyanping injection for treating community acquired pneumonia among adults in China. Value in Health. 2019; 22: S175.[C], 2019, S361-S361. |
APA | Shi, H.., Guo, W. J. ., Zhu, H.., Li, M.., Ung, O. L. C.., Hu, H.., & Han, S. (2019). PRS65 Effect and cost of traditional Chinese medicine Xiyanping injection for treating community acquired pneumonia among adults in China. Value in Health. 2019; 22: S175.. Value in Health, S361-S361. |
Files in This Item: | There are no files associated with this item. |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment